Penumbra
PEN
#1771
Rank
NZ$16.29 B
Marketcap
$424.67
Share price
-0.08%
Change (1 day)
3.18%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$1.95 Billion

According to Penumbra's latest financial reports the company has NZ$1.95 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Penumbra - Net assets on balance sheet (from 2014 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$1.86 B18.5%
2022-12-31$NZ$1.57 B12.95%
2021-12-31$NZ$1.39 B57.07%
2020-12-31$NZ$0.88 B23.19%
2019-12-31$NZ$0.71 B14.37%
2018-12-31$NZ$0.62 B11.65%
2017-12-31$NZ$0.56 B46.52%
2016-12-31$NZ$0.38 B13.14%
2015-12-31$NZ$0.34 B-2256.95%
2014-12-31$-NZ$15.77 Million60.64%
2013-12-31$-NZ$9.82 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$0.76 B-60.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.33 B 19.84%๐Ÿ‡บ๐Ÿ‡ธ USA